Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Active, Not Recruiting
Checked: April 18, 2026 at 12:24 AM UTC
| NCT Number | NCT06508658 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 360 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Genmab |
| Last Updated on CT.gov | April 8, 2026 (1 week ago) |
As of April 18, 2026: Clinical trial NCT06508658 is currently active_not_recruiting participants. This clinical trial study for diffuse large b-cell lymphoma is not currently accepting new participants at 17 locations across the United States. The study is sponsored by Genmab. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06508658 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06508658 was last updated 1 week ago (April 8, 2026). HelloStudys verifies this status automatically.